Finalist
Treatable Traits Medical Education Initiative
By GSK
With support from Prime
Summary of work
Treatable Traits is a global educational initiative to establish a new, patient-centric paradigm in the management of obstructive airways diseases, including asthma and COPD. The concept was originally conceived by a group of pioneering respiratory experts; it soon caught the attention of our client who was struck by how closely it aligned with their vision to support healthcare professionals (HCPs) in providing personalised patient care by proactively assessing their individual needs (‘traits’) and finding out what treatments would most benefit them.
After establishing a steering committee (SC) with the leading experts and an internal cross-functional working group, a comprehensive medical education strategy and plan was first developed in 2020. To date (2023), the strategy and plan have continued to evolve, including a comprehensive range of educational materials and activities, aligned with key audiences, channels, and objectives designed to effectively implement change. These have included various medical affairs materials, publications, digital omni-channel micro-content, multiple congress symposia, and a series of virtual standalone events (TADIS).
Feedback on the initiative and its related materials and activities has been consistently highly positive, and awareness and uptake of the concept in the wider community continues to grow.
Judges' comments
GSK and Prime’s concept was nicely thought through, with good objectives and structure. The feedback was positive, it read well with an all-encompassing structure.


